---
figid: PMC10537735__pharmaceutics-15-02248-g003
pmcid: PMC10537735
image_filename: pharmaceutics-15-02248-g003.jpg
figure_link: /pmc/articles/PMC10537735/figure/pharmaceutics-15-02248-f003/
number: Figure 3
figure_title: ''
caption: In vitro assessment of CRE-SD release after liposomal encapsulation. The
  percentages of the cumulative mass of CRE-SD released in liposomal CRE-SD and CRE-SD
  samples were measured from day 0 to 70, every 10 days (n = 3).
article_title: Modified Curcuminoid-Rich Extract Liposomal CRE-SDInhibits Osteoclastogenesis
  via the Canonical NF-κB Signaling Pathway.
citation: Sompot Jantarawong, et al. Pharmaceutics. 2023 Sep;15(9):2248.
year: '2023'

doi: 10.3390/pharmaceutics15092248
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI

keywords:
- curcuminoid
- liposomal CRE-SD
- osteoclastogenesis
- RANKL-stimulated RAW 264.7 macrophage
- canonical NF-κB signaling pathway

---
